文献速递白血病

急性髓系白血病中的黏连蛋白复合体突变

Cohesin mutations in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2024-09-09

本文综述了黏连蛋白复合体(由SMC3、SMC1A、RAD21和STAG2编码)在正常造血中的作用及其突变促进白血病转化的机制。文章讨论了DNA环化与染色质结构域的交互、姐妹染色单体黏连、DNA损伤反应和Polycomb抑制等最新进展,并关注携带黏连蛋白亚基突变的白血病细胞的潜在治疗脆弱性。

要点

  • 黏连蛋白复合体由SMC3、SMC1A、RAD21和STAG2编码,是DNA环化和基因表达的关键调控因子。
  • 黏连蛋白突变在急性髓系白血病等髓系恶性肿瘤中反复出现,但其促进癌症的精确机制尚不清楚。
  • 黏连蛋白在正常造血中的作用及其突变促进白血病转化的机制仍需进一步研究。

核心结论

  • 黏连蛋白在正常造血中的作用及黏连蛋白突变促进癌症的精确机制仍知之甚少。
  • 本综述讨论了黏连蛋白在正常造血中的作用及最新发现如何揭示其突变促进白血病转化的机制。

研究设计与样本

  • 本文为综述,讨论黏连蛋白复合体在正常造血中的作用及黏连蛋白突变促进白血病转化的机制。

主要发现

  • 黏连蛋白复合体由SMC3、SMC1A、RAD21和STAG2编码,是DNA环化和基因表达的关键调控因子。
  • 自首次在急性髓系白血病等髓系恶性肿瘤中鉴定出黏连蛋白亚基反复突变以来已超过十年。
  • 近期发现包括DNA环化与染色质结构域之间的交互、黏连蛋白建立姐妹染色单体黏连的深入理解、对黏连蛋白在DNA损伤反应中作用的重新关注以及黏连蛋白对Polycomb抑制重要性的证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 黏连蛋白在正常造血中的作用及黏连蛋白突变促进癌症的精确机制仍知之甚少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cohesin complex, encoded by SMC3, SMC1A, RAD21, and STAG2, is a critical regulator of DNA-looping and gene expression. Over a decade has passed since recurrent mutations affecting cohesin subunits were first identified in myeloid malignancies such as Acute Myeloid Leukemia (AML). Since that time there has been tremendous progress in our understanding of chromatin structure and cohesin biology, but critical questions remain because of the multiple critical functions the cohesin complex is responsible for. Recent findings have been particularly noteworthy with the identification of crosstalk between DNA-looping and chromatin domains, a deeper understanding of how cohesin establishes sister chromatid cohesion, a renewed interest in cohesin's role for DNA damage response, and work demonstrating cohesin's importance for Polycomb repression. Despite these exciting findings, the role of cohesin in normal hematopoiesis, and the precise mechanisms by which cohesin mutations promote cancer, remain poorly understood. This review discusses what is known about the role of cohesin in normal hematopoiesis, and how recent findings could shed light on the mechanisms through which cohesin mutations promote leukemic transformation. Important unanswered questions in the field, such as whether cohesin plays a role in HSC heterogeneity, and the mechanisms by which it regulates gene expression at a molecular level, will also be discussed. Particular attention will be given to the potential therapeutic vulnerabilities of leukemic cells with cohesin subunit mutations.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Boucher A, Murray J, Rao S, et al. Cohesin mutations in acute myeloid leukemia. Leukemia. 2024. PMID: 39251741. doi:10.1038/s41375-024-02406-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。